Target intelligence / Profile preview

Cell cycle checkpoint protein RAD1 (RAD1)

Target
RAD1
Molecular classification
DNA repair protein, Cell cycle checkpoint protein, Component of the 9-1-1 complex (heterotrimeric DNA damage sensor clamp), Sliding clamp protein (structurally related to PCNA)
01

Overview

Cell cycle checkpoint protein RAD1 is a core subunit of the heterotrimeric 9-1-1 clamp complex, which is essential for DNA damage checkpoint activation and DNA repair. Upon sensing DNA damage or replication stress, the 9-1-1 complex (comprising RAD9, RAD1, and HUS1) is loaded onto chromatin by the RAD17 complex, acting as a surveillance platform that recruits and stimulates various DNA repair enzymes. RAD1 plays a regulatory and structural role within the 9-1-1 complex, enabling interactions with DNA polymerases, endonucleases, ligases, and glycosylases involved in multiple DNA repair pathways. Through these functions, RAD1 is critical for maintaining genome stability, preventing cell cycle progression when DNA is damaged, and facilitating accurate DNA repair, particularly during DNA replication and meiosis[1][2][3][4]. Loss or dysfunction of RAD1 can lead to defective DNA damage responses, genomic instability, and is implicated in cancer predisposition syndromes.

Other names
RAD1 checkpoint DNA exonucleaseREC1hRAD1HRAD1Rad1-like DNA damage checkpoint proteinexonuclease homolog RAD1checkpoint control protein HRAD1DNA repair exonuclease REC1RAD1 checkpoint clamp componentRad1 homolog
02

Mechanism of action

No direct pharmacological mechanism; the target is not currently drugged, but inhibition or modulation would theoretically affect DNA damage response and repair

03

Biological functions

DNA damage sensingCell cycle checkpoint activationCoordination of DNA repair mechanismsStabilization of DNA repair complexesRecruitment and stimulation of DNA repair factors (polymerases, ligases, glycosylases, endonucleases)
04

Disease associations

Cancer (DNA repair and genome stability, e.g. Lynch syndrome subtypes)Genomic instability syndromesInfertility (when disrupted in meiosis in model organisms)
05

Safety considerations

Theoretical risk of genomic instability and increased cancer susceptibility if inhibited or lostPotential impact on normal tissue DNA repair during genotoxic therapies

Beyond the preview

Go deeper on Cell cycle checkpoint protein RAD1 (RAD1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell cycle checkpoint protein RAD1 (RAD1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call